ICON Public Limited Company logo
ICON Public Limited Company ICLR
$ 194.96 0.52%
report update icon

Quarterly report 2026-Q3
added 11-10-2026

ICON Public Limited Company Revenue | ICLR

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue ICON Public Limited Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
8.25 B 8.19 B 8.05 B 7.74 B 5.48 B 2.8 B 2.81 B 2.6 B 1.76 B 1.67 B 1.57 B 1.5 B 1.34 B 1.12 B 946 M 900 M 888 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
8.25 B 888 M 3.39 B

Quarterly Revenue ICON Public Limited Company

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q4 2009-Q4 2008-Q4 2007-Q4
2.02 B 2.06 B 2.03 B 2.11 B 2.08 B 2.04 B 2.02 B 2.06 B 2.04 B 2.04 B 2.04 B 2.04 B 2.04 B 2.01 B 1.97 B 1.96 B 1.94 B 1.94 B 1.9 B 1.89 B 1.87 B 871 M 858 M 760 M 702 M 620 M 715 M 725 M 710 M 695 M 675 M 679 M 655 M 642 M 620 M 455 M 440 M 431 M 432 M - 420 M 411 M 401 M - 395 M 389 M 388 M - 388 M 376 M 350 M 345 M 340 M 334 M 317 M 300 M 286 M 277 M 252 M 243 M 241 M 233 M 229 M 900 M 888 M - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.11 B 229 M 1.01 B

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Diagnostics research industry

Issuer Revenue Price % 24h Market Cap Country
Fluidigm Corporation Fluidigm Corporation
FLDM
138 M - 1.08 % $ 308 M usaUSA
Senseonics Holdings Senseonics Holdings
SENS
35.3 M $ 9.76 -3.99 % $ 407 M usaUSA
Sotera Health Company Sotera Health Company
SHC
1.16 B $ 16.27 1.34 % $ 4.62 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
622 K $ 0.2 1.99 % $ 266 K usaUSA
Precipio Precipio
PRPO
24 M $ 18.8 -1.93 % $ 30.2 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
3.18 B - - $ 10.7 B usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
17.8 B $ 29.82 -0.23 % $ 28.3 B niderlandNiderland
DarioHealth Corp. DarioHealth Corp.
DRIO
22.4 M $ 1.42 23.48 % $ 5.66 M israelIsrael
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
44.6 B $ 691.66 0.71 % $ 261 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
824 M $ 5.54 -0.09 % $ 513 M usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
6.17 K $ 4.04 2.93 % $ 5.35 M usaUSA
RadNet RadNet
RDNT
2.04 B $ 72.01 -3.88 % $ 5.41 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
2.09 B $ 49.57 -0.37 % $ 10.8 B niderlandNiderland
NeoGenomics NeoGenomics
NEO
727 M $ 15.31 0.36 % $ 1.96 B usaUSA
OPKO Health OPKO Health
OPK
148 M $ 1.7 4.63 % $ 1.28 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
160 M $ 1.85 1.65 % $ 555 M usaUSA
Neogen Corporation Neogen Corporation
NEOG
870 M $ 11.08 1.61 % $ 2.41 B usaUSA
Personalis Personalis
PSNL
69.6 M $ 14.97 1.15 % $ 1.34 B usaUSA
Quidel Corporation Quidel Corporation
QDEL
1.66 B $ 9.62 -2.53 % $ 405 M usaUSA
Centogene N.V. Centogene N.V.
CNTG
128 M - -6.23 % $ 30.6 M germanyGermany
Neuronetics Neuronetics
STIM
149 M $ 1.25 -1.95 % $ 82.4 M usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
61.6 M $ 5.83 -3.08 % $ 2.09 B irlandaIrlanda
Global Cord Blood Corporation Global Cord Blood Corporation
CO
1.24 B - - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
7.66 M - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
651 M - 0.12 % $ 80.1 M chinaChina
Exagen Exagen
XGN
66.6 M $ 3.91 3.99 % $ 84.3 M usaUSA
VolitionRx Limited VolitionRx Limited
VNRX
1.73 M $ 0.18 -4.72 % $ 22.6 M singaporeSingapore
Waters Corporation Waters Corporation
WAT
932 M $ 466.25 3.66 % $ 27.8 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
343 K - -6.19 % $ 10.5 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
3.25 B - - $ 19.8 B usaUSA
National Research Corporation National Research Corporation
NRC
137 M $ 26.17 1.08 % $ 586 M usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
459 M $ 116.3 3.84 % $ 7.28 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
131 K - -2.3 % $ 19.4 M usaUSA
OpGen OpGen
OPGN
30.2 M - -16.95 % $ 1.54 M usaUSA
PerkinElmer PerkinElmer
PKI
2.86 B - -0.91 % $ 14.7 B usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
190 M - - $ 2.69 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
31.9 M - -8.98 % $ 14.8 K usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
2.29 M - 5.66 % $ 22.7 M britainBritain
DexCom DexCom
DXCM
4.66 B $ 82.53 0.6 % $ 32.2 B usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
333 M - - $ 1.49 B usaUSA
Heska Corporation Heska Corporation
HSKA
257 M - - $ 1.31 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
11.7 M - -61.36 % $ 2.46 M usaUSA
T2 Biosystems T2 Biosystems
TTOO
7.19 M - -39.35 % $ 313 K usaUSA
Syneos Health Syneos Health
SYNH
5.39 B - - $ 4.46 B usaUSA
Biocept Biocept
BIOC
25.9 M - -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
122 M - - $ 21.2 M usaUSA
Quotient Limited Quotient Limited
QTNT
38.5 M - -11.32 % $ 1.1 M schweizSchweiz